483 related articles for article (PubMed ID: 8806796)
21. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
[TBL] [Abstract][Full Text] [Related]
22. Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage.
Johnson BD; Nardella JP; McConnell TJ; Mannie MD
Cell Immunol; 1997 Jul; 179(1):55-65. PubMed ID: 9259772
[TBL] [Abstract][Full Text] [Related]
23. Myelin basic protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat.
Zehetbauer B; Massacesi L; Liuzzi GM; Vergelli M; Olivotto J; Grassi L; Riccio P; Amaducci L
Acta Neurol (Napoli); 1991 Apr; 13(2):121-32. PubMed ID: 1716398
[TBL] [Abstract][Full Text] [Related]
24. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins.
Achiron A; Mor F; Margalit R; Cohen IR; Lider O; Miron S
J Autoimmun; 2000 Nov; 15(3):323-30. PubMed ID: 11040073
[TBL] [Abstract][Full Text] [Related]
25. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
Swierkosz JE; Swanborg RH
J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
McCombe PA; Nickson I; Tabi Z; Pender MP
J Neurol Sci; 1996 Jul; 139(1):1-6. PubMed ID: 8836965
[TBL] [Abstract][Full Text] [Related]
27. [Inhibiton of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99].
Sun B; Yang S; Peng HS; Qiao H; Cao JY; Jin LH; Li HL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):106-9. PubMed ID: 17286899
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE.
Lake J; Weller RO; Phillips MJ; Needham M
J Pathol; 1999 Jan; 187(2):259-65. PubMed ID: 10365103
[TBL] [Abstract][Full Text] [Related]
30. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
[TBL] [Abstract][Full Text] [Related]
31. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.
Brostoff SW; Mason DW
J Immunol; 1984 Oct; 133(4):1938-42. PubMed ID: 6236260
[TBL] [Abstract][Full Text] [Related]
32. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.
Raine CS; Cannella B; Duijvestijn AM; Cross AH
Lab Invest; 1990 Oct; 63(4):476-89. PubMed ID: 1700193
[TBL] [Abstract][Full Text] [Related]
33. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
[TBL] [Abstract][Full Text] [Related]
34. Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
Weissert R; Svenningsson A; Lobell A; de Graaf KL; Andersson R; Olsson T
J Immunol; 1998 Jan; 160(2):681-90. PubMed ID: 9551903
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen.
Holda JH; Welch AM; Swanborg RH
Eur J Immunol; 1980 Aug; 10(8):657-9. PubMed ID: 6967418
[TBL] [Abstract][Full Text] [Related]
37. Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats.
Held W; Meyermann R; Qin Y; Mueller C
J Autoimmun; 1993 Jun; 6(3):311-22. PubMed ID: 7691064
[TBL] [Abstract][Full Text] [Related]
38. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes.
Matsumoto Y; Hanawa H; Tsuchida M; Abo T
Immunology; 1993 Jul; 79(3):381-90. PubMed ID: 7691723
[TBL] [Abstract][Full Text] [Related]
39. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
Panitch HS; McFarlin DE
J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
[TBL] [Abstract][Full Text] [Related]
40. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
